- Home
- SONN vs NBY Comparison
SONN vs NBY Comparison
Compare SONN & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- NBY
- Stock Information
- Founded
- SONN N/A
- NBY 2000
- Country
- SONN United States
- NBY United States
- Employees
- SONN N/A
- NBY N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- NBY
- Sector
- SONN Health Care
- NBY
- Exchange
- SONN Nasdaq
- NBY Nasdaq
- Market Cap
- SONN 2.5M
- NBY 2.8M
- IPO Year
- SONN N/A
- NBY 2007
- Fundamental
- Price
- SONN $1.62
- NBY $0.65
- Analyst Decision
- SONN Strong Buy
- NBY Strong Buy
- Analyst Count
- SONN 2
- NBY 1
- Target Price
- SONN $38.00
- NBY $0.85
- AVG Volume (30 Days)
- SONN 282.7K
- NBY 502.1K
- Earning Date
- SONN 02-12-2025
- NBY 03-25-2025
- Dividend Yield
- SONN N/A
- NBY N/A
- EPS Growth
- SONN N/A
- NBY N/A
- EPS
- SONN N/A
- NBY N/A
- Revenue
- SONN $18,626.00
- NBY $13,844,000.00
- Revenue This Year
- SONN N/A
- NBY N/A
- Revenue Next Year
- SONN N/A
- NBY $17.31
- P/E Ratio
- SONN N/A
- NBY N/A
- Revenue Growth
- SONN N/A
- NBY 15.40
- 52 Week Low
- SONN $1.41
- NBY $0.36
- 52 Week High
- SONN $18.72
- NBY $9.10
- Technical
- Relative Strength Index (RSI)
- SONN 42.90
- NBY 49.67
- Support Level
- SONN $1.64
- NBY $0.60
- Resistance Level
- SONN $2.05
- NBY $0.84
- Average True Range (ATR)
- SONN 0.17
- NBY 0.07
- MACD
- SONN 0.03
- NBY -0.01
- Stochastic Oscillator
- SONN 24.59
- NBY 26.79
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.